INVIBIO Trademark
Serial Number: 79367445 • Registration: 7307540
INVIBIO is a trademark filed by
Invibio Limited
on November 21, 2022. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
David W. Staple Casimir Jones, S.C.
2275 Deming Way
Suite 310
Middleton
WI 53562
Trademark Details
Filing Date
November 21, 2022
Registration Date
February 20, 2024
Published for Opposition
December 5, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 25, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 7, 2024 FICS
FINAL DISPOSITION PROCESSED
Aug 6, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 21, 2024 FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 21, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 20, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 20, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 5, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Dec 4, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 15, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 15, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2023 TROA
REFUSAL PROCESSED BY IB
Oct 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 27, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 27, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 9, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 8, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 18, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 13, 2023 REPR
